Search Results - "Xin, Minhang"

Refine Results
  1. 1

    Small molecule selenium-containing compounds: Recent development and therapeutic applications by Chuai, Hongyan, Zhang, San-Qi, Bai, Huanrong, Li, Jiyu, Wang, Yang, Sun, Jiajia, Wen, Ergang, Zhang, Jiye, Xin, Minhang

    Published in European journal of medicinal chemistry (05-11-2021)
    “…Selenium (Se) is an essential micronutrient of organism and has important function. It participates in the functions of selenoprotein in several manners. In…”
    Get full text
    Journal Article
  2. 2

    Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y by Liang, Chengyuan, Tian, Danni, Liu, Yuzhi, Li, Han, Zhu, Jialiang, Li, Min, Xin, Minhang, Xia, Juan

    Published in European journal of medicinal chemistry (15-07-2019)
    “…Ganoderma lucidum is a multi-purpose plant medicine that is homologous to functional food. The most attractive properties of G. lucidum are its…”
    Get full text
    Journal Article
  3. 3

    Strategies to target the Hedgehog signaling pathway for cancer therapy by Xin, Minhang, Ji, Xinyue, La Cruz, Ladie Kimberly, Thareja, Suresh, Wang, Binghe

    Published in Medicinal research reviews (01-05-2018)
    “…Hedgehog (Hh) signaling is an essential pathway in the human body, and plays a major role in embryo development and tissue patterning. Constitutive activation…”
    Get full text
    Journal Article
  4. 4

    Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC) by Zhang, Hao, Zhao, Hong-Yi, Xi, Xiao-Xiao, Liu, Yan-Jie, Xin, Minhang, Mao, Shuai, Zhang, Jun-Jie, Lu, A-Xin, Zhang, San-Qi

    Published in European journal of medicinal chemistry (01-03-2020)
    “…Epidermal growth factor receptor (EGFR), a member of the HER family, is closely related to the development of multiple cancers. Herein, we report the discovery…”
    Get full text
    Journal Article
  5. 5

    Progress of small molecules for targeted protein degradation: PROTACs and other technologies by Zhao, Hong‐Yi, Xin, Minhang, Zhang, San‐Qi

    Published in Drug development research (01-04-2023)
    “…Recent years have witnessed the rapid development of targeted protein degradation (TPD), especially proteolysis targeting chimeras. These degraders have…”
    Get full text
    Journal Article
  6. 6

    Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R/T790M/C797S mutant EGFR tyrosine kinase inhibitors by Lei, Hao, Fan, Shu, Zhang, Hao, Liu, Yan-Jie, Hei, Yuan-Yuan, Zhang, Jun-Jie, Zheng, A-Qun, Xin, Minhang, Zhang, San-Qi

    Published in European journal of medicinal chemistry (15-01-2020)
    “…Targeting L858R/T790M/C797S mutant EGFR is a major challenge in the new-generation EGFR tyrosine kinase inhibitors development for conquering drug resistant…”
    Get full text
    Journal Article
  7. 7

    Design and synthesis of novel phthalazinone derivatives as potent poly(ADP-ribose)polymerase 1 inhibitors by Xin, Minhang, Sun, Jiajia, Huang, Wei, Tang, Feng, Liu, Zhaoyu, Jin, Qiu, Wang, Jia

    Published in Future medicinal chemistry (01-10-2020)
    “…The development of effective PARP-1 inhibitors has received great enthusiasm in medicinal chemistry communities. A new series of novel phthalazinone…”
    Get full text
    Journal Article
  8. 8

    Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors by Hei, Yuan-Yuan, Wang, Si, Xi, Xiao-Xiao, Wang, Hai-Peng, Guo, Yuanxu, Xin, Minhang, Jiang, Congshan, Lu, Shemin, Zhang, San-Qi

    Published in Journal of pharmaceutical analysis (01-08-2022)
    “…MicroRNA-21 (miRNA-21) is highly expressed in various tumors. Small-molecule inhibition of miRNA-21 is considered to be an attractive novel cancer therapeutic…”
    Get full text
    Journal Article
  9. 9

    Cu-mediated selective bromination of aniline derivatives and preliminary mechanism study by Zhao, Hong-Yi, Yang, Xue-Yan, Lei, Hao, Xin, Minhang, Zhang, San-Qi

    Published in Synthetic communications (03-06-2019)
    “…A simple and efficient bromination of aniline, aniline derivatives, and analogs have been developed. Forty three examples were given and the highest yield…”
    Get full text
    Journal Article
  10. 10
  11. 11

    An efficient, practical synthesis of 2-methoxyestradiol by Xin, Minhang, You, Qidong, Xiang, Hua

    Published in Steroids (2010)
    “…An efficient and practical scheme to synthesize 2-methoxyestradiol has been developed. The key step was the copper-mediated methoxylation using ethyl acetate…”
    Get full text
    Journal Article
  12. 12

    Hedgehog inhibitors: a patent review (2013 - present) by Xin, Minhang

    Published in Expert opinion on therapeutic patents (01-05-2015)
    “…The hedgehog (Hh) signaling pathway is an important signaling pathway, playing a critical role in regulation of cell growth, development, metastasis and…”
    Get more information
    Journal Article
  13. 13

    The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review by Liang, Chengyuan, Tian, Danni, Ren, Xiaodong, Ding, Shunjun, Jia, Minyi, Xin, Minhang, Thareja, Suresh

    Published in European journal of medicinal chemistry (10-05-2018)
    “…Bruton's tyrosine kinase (BTK) has emerged as a promising drug target for multiple diseases, particularly haematopoietic malignancies and autoimmune diseases…”
    Get full text
    Journal Article
  14. 14

    PI3Kδ inhibitors for the treatment of cancer: a patent review (2015-present) by Feng, Yifan, Cu, Xiaochuan, Xin, Minhang

    Published in Expert opinion on therapeutic patents (02-12-2019)
    “…: PI3Kδ is an important subtype of PI3K kinases, which is mainly expressed in leukocytes and plays an important role in the proliferation, differentiation,…”
    Get more information
    Journal Article
  15. 15

    Modification of osimertinib to discover new potent EGFRC797S-TK inhibitors by Xi, Xiao-Xiao, Zhao, Hong-Yi, Mao, Yu-Ze, Xin, Minhang, Zhang, San-Qi

    Published in European journal of medicinal chemistry (05-12-2023)
    “…The EGFRC797S mutation is a dominant mechanism of acquired resistance after the treatment of non-small cell lung cancer (NSCLC) with osimertinib in clinic. To…”
    Get full text
    Journal Article
  16. 16

    Discovery of potent small molecule PROTACs targeting mutant EGFR by Zhao, Hong-Yi, Yang, Xue-Yan, Lei, Hao, Xi, Xiao-Xiao, Lu, She-Min, Zhang, Jun-Jie, Xin, Minhang, Zhang, San-Qi

    Published in European journal of medicinal chemistry (15-12-2020)
    “…Epidermal growth factor receptor (EGFR) is an important therapeutic target for the treatment of non-small cell lung cancer. A number of efficacious EGFR…”
    Get full text
    Journal Article
  17. 17

    Menin-MLL protein-protein interaction inhibitors: a patent review (2014-2021) by Bai, Huanrong, Zhang, San-Qi, Lei, Hao, Wang, Fang, Ma, Mengyan, Xin, Minhang

    Published in Expert opinion on therapeutic patents (04-05-2022)
    “…Chromosomal translocations involving the mixed-lineage leukemia (MLL, KMT2A, MLL1) genes result in the production of MLL fusion proteins, which cause abnormal…”
    Get more information
    Journal Article
  18. 18

    Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors by Sun, Jiajia, Feng, Yifan, Huang, Yuan, Zhang, San-Qi, Xin, Minhang

    Published in Bioorganic & medicinal chemistry letters (01-10-2020)
    “…[Display omitted] PI3Kδ in B cells mediates antigen receptor signaling and promote neutrophil chemotaxis. The activation of PI3Kδ can cause mast cell…”
    Get full text
    Journal Article
  19. 19

    Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands by Zhao, Hong-Yi, Wang, Hai-Peng, Mao, Yu-Ze, Zhang, Hao, Xin, Minhang, Xi, Xiao-Xiao, Lei, Hao, Mao, Shuai, Li, Dong-Hui, Zhang, San-Qi

    Published in Journal of medicinal chemistry (24-03-2022)
    “…Drug resistance caused by epidermal growth factor receptor (EGFR) mutation has largely limited the clinical use of EGFR tyrosine kinase inhibitors (EGFR-TKIs)…”
    Get full text
    Journal Article
  20. 20

    Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia by Lei, Hao, Zhang, San-Qi, Fan, Shu, Bai, Huan-Rong, Zhao, Hong-Yi, Mao, Shuai, Xin, Minhang

    Published in Journal of medicinal chemistry (11-11-2021)
    “…Mixed lineage leukemia (MLL) gene rearrangements are associated with acute leukemia. The protein menin is regarded as a critical oncogenic cofactor of the…”
    Get full text
    Journal Article